PCAS More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Pierre Luzeau
CHM | Chairman | 60 | 17-06-19 |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 99-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pierre Luzeau
CHM | Chairman | 60 | 17-06-19 |
| Director/Board Member | 72 | 14-02-28 | |
Janine Cossy
BRD | Director/Board Member | - | - |
PCAS specializes in developing, manufacturing, and marketing fine and specialty chemicals. Sales are distributed by family of products as follows:
- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
